Cell & Molecular Technologies Inc
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
In February 2005, Sentigen Holding has sold the Specialty Media Division of its wholly owned subsidiary, Cell & Molecular Technologies to Chemicon International, a wholly owned subsidiary of Serologicals Corporation. Cell & Molecular Technologies, Inc. (CMT) is a wholly owned subsidury of Sentigen Holding. The firm provides contract research and development services for the pharmaceutical, biotechnology, and biomedical research communities.

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
A High-Level Expression Plasmid With A Broad Host Range
Kit For Contructing Es Cell/Blastocyst Chimeras